Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Chromosome 17 deletion × pomalidomide × Clear all

Phase

Status

Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 53 Recurrence 17 Neoplasms, Plasma Cell 6 Primary Myelofibrosis 3 Myeloproliferative Disorders 3 Renal Insufficiency 2 Polycythemia Vera 2 Plasmacytoma 2 Lymphoma, Non-Hodgkin 2 Immunoglobulin Light-chain Amyloidosis 2 Central Nervous System Neoplasms 2 Waldenstrom Macroglobulinemia 1 Unspecified Adult Solid Tumor, Protocol Specific 1 Thrombocythemia, Essential 1 Sarcoma, Kaposi 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Optic Nerve Glioma 1 Neurofibromatosis 1 1 Neoplasms 1 Medulloblastoma 1 Leukemia, Plasma Cell 1 Leukemia, Myeloid, Acute 1 Leukemia, Megakaryoblastic, Acute 1 Hodgkin Disease 1 Glioma 1 Ependymoma 1 Disease Progression 1 Disease 1 Chromosome 17 deletion 1

Interventions

fludarabine phosphate 4 venetoclax 3 Peripheral Blood Stem Cell Transplantation 3 ibrutinib 2 Whole-Body Irradiation 2 Tacrolimus 2 Mycophenolic Acid 2 Melphalan 2 Dexamethasone 2 pomalidomide 1 pembrolizumab 1 obinutuzumab 1 ixazomib 1 fludarabine 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1 carmustine, poliferprosan 20 drug combination 1 auricularum 1 acalabrutinib 1 Sirolimus 1 RG7388 1 Nivolumab 1 Etoposide 1 Cytarabine 1 Cyclosporins 1 Cyclosporine 1 Cyclophosphamide 1 Carmustine 1 Calcium Dobesilate 1 Bortezomib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01745640 2026-02-05

IFM2010-02

University Hospital, Lille

Phase 2 Completed

Chromosome 17 deletion, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡